Jonathan Tunnicliffe

Mr. Tunnicliffe has over 23 years of experience in the biopharmaceutical industry. From 2000, he was global head of due diligence for the NQ business unit of Quintiles.

He also performed a leadership role in the ongoing management, origination, structuring and contracting of investments. Mr. Tunnicliffe was previously a founding member and Director of Operations of a specialized clinical research organization, S-Cubed where he led all operational functions. In Mr. Tunnicliffe’s earlier career, he was a medical statistician at SmithKline and French (now Glaxo SmithKline) and at the University of Sheffield.

Mr. Tunnicliffe has a Bachelor’s degree in Mathematical Statistics from the University of Liverpool, a Master of Science in Medical Statistics from the University of Newcastle-upon-Tyne and an MBA from Sheffield Hallam University.

He also holds a Postgraduate Diploma in Marketing from the Chartered Institute of Marketing in the United Kingdom.

Jonathan Tunnicliffe is the Director at Revance Therapeutics. With a background in Biotechnology, Jonathan Tunnicliffe has a rich history of leadership and innovation. Jonathan Tunnicliffe studied MS Medical Statistics @ Newcastle University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.